Crossmark

Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results

Crossref DOI link: https://doi.org/10.1016/j.arbres.2021.02.003

Published Print: 2021-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sánchez-Martínez, Francesca

Arenas-Miras, Mar

Jové-Caballé, Neus

Knobel-Freud, Hernando
License Information

Text and Data Mining valid from 2021-04-01
More Information

This article is maintained by: Elsevier

Article Title: Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2021.02.003

Content Type: simple-article

Copyright: © 2021 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.